BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35200583)

  • 1. Metabolic Activity Assessment by 18F-Fluorodeoxyglucose Positron Emission Tomography in Patients after COVID-19 Vaccination.
    Shalata W; Levin D; Fridman J; Makarov V; Iraqi M; Golosky M; Rouvinov K; Kian W; Yakobson A
    Curr Oncol; 2022 Feb; 29(2):989-1000. PubMed ID: 35200583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [
    Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
    Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and Characteristics of Nodal and Deltoid FDG and
    Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
    AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
    [No Abstract]   [Full Text] [Related]  

  • 4. The systemic impact of different COVID-19 vaccines in 2-[18F] FDG-PET/CT.
    Nazerani-Zemann T; Pernthaler B; Schwantzer G; Gstettner C
    Sci Rep; 2023 Dec; 13(1):21838. PubMed ID: 38071353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactive Axillary Lymphadenopathy to COVID-19 Vaccination on
    Smith MV; Yang M
    J Nucl Med Technol; 2021 Sep; 49(3):286-287. PubMed ID: 33820864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subdiaphragmatic Lymph Nodes Uptake on 18F-FDG PET/CT After COVID-19 Vaccination in the Thigh.
    Quak E; Morel A; Faudemer J; Levy C; Ciappuccini R
    Clin Nucl Med; 2022 Mar; 47(3):275-276. PubMed ID: 34661560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. COVID-19 vaccination induced axillary nodal uptake on [18F]FDG PET/CT.
    Nawwar AA; Searle J; Hagan I; Lyburn ID
    Eur J Nucl Med Mol Imaging; 2021 Jul; 48(8):2655-2656. PubMed ID: 33638003
    [No Abstract]   [Full Text] [Related]  

  • 8. Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [
    Cohen D; Krauthammer SH; Wolf I; Even-Sapir E
    Eur J Nucl Med Mol Imaging; 2021 Jun; 48(6):1854-1863. PubMed ID: 33774684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COVID-19 Vaccination-Associated Lymphadenopathy on FDG PET/CT: Distinctive Features in Adenovirus-Vectored Vaccine.
    Shin M; Hyun CY; Choi YH; Choi JY; Lee KH; Cho YS
    Clin Nucl Med; 2021 Oct; 46(10):814-819. PubMed ID: 34115709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Challenge of Staging Breast Cancer With PET/CT in the Era of COVID Vaccination.
    Brown AH; Shah S; Groves AM; Wan S; Malhotra A
    Clin Nucl Med; 2021 Dec; 46(12):1006-1010. PubMed ID: 33795590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DOTATATE Uptake in an Axillary Lymph Node After COVID-19 Vaccination.
    Brophy J; Henkle G; Rohren EM
    Clin Nucl Med; 2022 Feb; 47(2):174-175. PubMed ID: 34269723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypermetabolic abdominal and cervical lymph nodes mimicking Hodgkin lymphoma relapse on FDG PET/CT after adenovirus-vectored COVID-19 vaccine.
    Landete E; Gómez-Fernández I; González-Gascón-Y-Marín I; Durán-Barquero C; Churruca J; Infante MS; Muñoz-Novas C; Foncillas MÁ; Marín K; Ramos-de-Ascanio V; Alonso-Farto JC; Hernández-Rivas JÁ
    Hum Vaccin Immunother; 2021 Dec; 17(12):5129-5132. PubMed ID: 34920695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of metabolic changes in FDG PET/CT imaging after mRNA-based COVID-19 vaccination.
    İşgören S; Köroğlu G; Görür GD; Demir H
    Turk J Med Sci; 2022 Dec; 52(6):1745-1753. PubMed ID: 36945983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensity of hypermetabolic axillary lymph nodes in oncologic patients in relation to timeline following COVID-19 vaccination.
    Su N; Wiefels C; Klein R; Zeng W; Abbaspour F
    J Med Imaging Radiat Sci; 2022 Jun; 53(2):219-225. PubMed ID: 35131216
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Features of Systemic Immune Response From COVID-19 Vaccination on 18F-FDG PET/CT.
    Nawwar AA; Searle J; Lyburn ID
    Clin Nucl Med; 2022 Jan; 47(1):e89-e90. PubMed ID: 34269722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of Increased FDG PET/CT Axillary Lymph Node Uptake Beyond 6 Weeks after mRNA COVID-19 Vaccination.
    Eshet Y; Tau N; Alhoubani Y; Kanana N; Domachevsky L; Eifer M
    Radiology; 2021 Sep; 300(3):E345-E347. PubMed ID: 33904778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-Positive Axillary Lymph Nodes on FDG PET/CT Resulting From COVID-19 Immunization.
    Nawwar AA; Searle J; Hopkins R; Lyburn ID
    Clin Nucl Med; 2021 Dec; 46(12):1004-1005. PubMed ID: 33883486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing immune response upon systemic RNA vaccination on [18F]-FDG PET/CT for COVID-19 vaccine and then for immuno-oncology?
    Seban RD; Champion L; Yeh R; Schwartz LH; Dercle L
    Eur J Nucl Med Mol Imaging; 2021 Oct; 48(11):3351-3352. PubMed ID: 34164727
    [No Abstract]   [Full Text] [Related]  

  • 19. Lessons Learned from Post-COVID-19 Vaccination PET/CT Studies.
    Orevi M; Chicheportiche A; Ben Haim S
    J Nucl Med; 2022 Mar; 63(3):453-460. PubMed ID: 34301777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic Immune Response Syndrome After COVID-19 Immunization-Initial and Follow-up 18F-FDG PET/CT Imaging Appearances.
    Nawwar AA; Searle J; Hagan I; Lyburn ID
    Clin Nucl Med; 2022 Mar; 47(3):e327-e328. PubMed ID: 35025792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.